OI 77, a new tricyclic antidepressant.
D000374:Aggression / Q000187:drug effects; D000661:Amphetamine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D004357:Drug Synergism; D004597:Electroshock; D004924:Escape Reaction / Q000187:drug effects; D006801:Humans; D007928:Lethal Dose 50; D008744:Methylamines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010546:Perphenazine / Q000037:antagonists & inhibitors; D010617:Phenanthridines / Q000494:pharmacology*; D004856:Postural Balance / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012472:Salivation / Q000187:drug effects; D012640:Seizures / Q000517:prevention & control; D012890:Sleep / Q000187:drug effects; D012919:Social Behavior / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D014203:Tremorine / Q000037:antagonists & inhibitors; D014363:Tryptamines / Q000037:antagonists & inhibitors; D014456:Ulcer / Q000517:prevention & control
D000700:Analgesics; D000928:Antidepressive Agents; D008744:Methylamines; D010617:Phenanthridines; D014363:Tryptamines; D012110:Reserpine; D000661:Amphetamine; D010546:Perphenazine; D014203:Tremorine; D010433:Pentylenetetrazole